Publication: HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients in Asia: Results from the TREAT Asia studies to evaluate resistance-monitoring study
Issued Date
2011-04-15
Resource Type
ISSN
15376591
10584838
10584838
Other identifier(s)
2-s2.0-79953837870
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical Infectious Diseases. Vol.52, No.8 (2011), 1053-1057
Suggested Citation
Somnuek Sungkanuparph, Rebecca Oyomopito, Sunee Sirivichayakul, Thira Sirisanthana, Patrick C.K. Li, Pacharee Kantipong, Christopher K.C. Lee, Adeeba Kamarulzaman, Liesl Messerschmidt, Matthew G. Law, Praphan Phanuphak HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients in Asia: Results from the TREAT Asia studies to evaluate resistance-monitoring study. Clinical Infectious Diseases. Vol.52, No.8 (2011), 1053-1057. doi:10.1093/cid/cir107 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/12541
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients in Asia: Results from the TREAT Asia studies to evaluate resistance-monitoring study
Other Contributor(s)
Abstract
(See editorial commentary by Jordan on pages 1058-1060.)Of 682 antiretroviral-naïve patients initiating antiretroviral therapy in a prospective, multicenter human immunodeficiency virus type 1 (HIV-1) drug resistance monitoring study involving 8 sites in Hong Kong, Malaysia, and Thailand, the prevalence of patients with ≥1 drug resistance mutation was 13.8%. Primary HIV drug resistance is emerging after rapid scaling-up of antiretroviral therapy use in Asia. © 2011 The Author.